Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer

Inclusion criteria: * 18 years old to 70 years * Primary non small cell lung cancer (stage 3 and 4) * Subjects must have had their last cancer therapy at least four weeks prior to entry to this study * The patient must be willing and able to sign the informed consent prior to the start of the trial * Candidates are not currently receiving cancer therapy (chemotherapy, molecular targeted drug therapy, and radiation therapy) * Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 * Willingness to comply with the weekly phone calls between office visits * Patients must be able to take food orally or have peg tube for feeding * Life expectancy of at least 6 months Exclusion Criteria: * Lung metastasis/not primary non small cell lung cancer * Glucose-6-phosphate dehydrogenase deficiency (G6PD) * Vitamin C allergy * Impossibility to place the patient into the mEHT machine * Metallic implants or replacements in the treatment area * Electronic implanted devices anywhere * Missing or damaged heat-sense nerves or other field-sensitive issues in the treatment area * Co-morbid conditions that affect survival: end stage congestive heart failure, unstable angina, myocardial infarction (within the past 6 weeks), and uncontrolled blood sugars of greater than 300 mg/dL, known chronic active hepatitis or cirrhosis * Renal insufficiency as evidenced by serum creatinine of ≥ 1.3mg/dl or evidence of oxalosis by urinalysis * Chronic hemodialysis * Iron overload (a ferritin \> 500 ng/ml) * Wilson's disease * Compromised liver function with evidence of complete biliary obstruction or have a serum bilirubin of 2.0 or liver function tests (AST \> 63, ALT \> 95) exceeding 1.5 x the upper limit of normal * Very low white blood cell count (\< 1.5 x 10(9)/L), agranulocytosis (\< 0.5 x 10(9)/L) or severe anemia * Pregnant or lactating female * Current tobacco use * Evidence of significant psychiatric disorder by history or examination that would prevent completion of the study or preclude informed consent